Cheng J C, Chao K S, Low D
Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University Medical Center, St. Louis, Missouri, USA.
Int J Cancer. 2001 Apr 20;96(2):126-31. doi: 10.1002/ijc.1004.
We studied target volume coverage and normal tissue sparing of serial tomotherapy intensity modulated radiation therapy (IMRT) and fixed-field IMRT for nasopharyngeal carcinoma (NPC), as compared with those of conventional beam arrangements. Twelve patients with NPC (T2-4N1-3M0) at Mallinckrodt Institute of Radiology underwent computed tomography simulation. Images were then transferred to a virtual simulation workstation computer for target contouring. Target gross tumor volumes (GTV) were primary nasopharyngeal tumor (GTV(NP)) with a prescription of 70 Gy, grossly enlarged cervical nodes (GTV(LN)) with a prescription of 70 Gy, and the uninvolved cervical lymphatics [designated as the clinical tumor volume (CTV)] with a prescription of 60 Gy. Critical organs, including the parotid gland, spinal cord, brain stem, mandible, and pituitary gland, were also delineated. Conventional beam arrangements were designed following the guidelines of Intergroup (SWOG, RTOG, ECOG) NPC Study 0099 in which the dose was prescribed to the central axis and the target volumes were aimed to receive the prescribed dose +/- 10%. Similar dosimetric criteria were used to assess the target volume coverage capability of IMRT. Serial tomotherapy IMRT was planned using a 0.86-cm wide multivane collimator, while a dynamic multileaf collimator system with five equally spaced fixed gantry angles was designated for fixed-beam IMRT. The fractional volume of each critical organ that received a certain predefined threshold dose was obtained from dose-volume histograms of each organ in either the three-dimensional or IMRT treatment planning computer systems. Statistical analysis (paired t-test) was used to examine statistical significance. We found that serial tomotherapy achieved similar target volume coverage as conventional techniques (97.8 +/- 2.3% vs. 98.9 +/- 1.3%). The static-field IMRT technique (five equally spaced fields) was inferior, with 92.1 +/- 8.6% fractional GTV(NP) receiving 70 Gy +/- 10% dose (P < 0.05). However, GTV(LN) coverage of 70 Gy was significantly better with both IMRT techniques (96.1 +/- 3.2%, 87.7 +/- 10.6%, and 42.2 +/- 21% for tomotherapy, fixed-field IMRT, and conventional therapy, respectively). CTV coverage of 60 Gy was also significantly better with the IMRT techniques. Parotid gland sparing was quantified by evaluating the fractional volume of parotid gland receiving more than 30 Gy; 66.6 +/- 15%, 48.3 +/- 4%, and 93 +/- 10% of the parotid volume received more than 30 Gy using tomotherapy, fixed-field IMRT, and conventional therapy, respectively (P < 0.05). Fixed-field IMRT technique had the best parotid-sparing effect despite less desirable target coverage. The pituitary gland, mandible, spinal cord, and brain stem were also better spared by both IMRT techniques. These encouraging dosimetric results substantiate the theoretical advantage of inverse-planning IMRT in the management of NPC. We showed that target coverage of the primary tumor was maintained and nodal coverage was improved, as compared with conventional beam arrangements. The ability of IMRT to spare the parotid glands is exciting, and a prospective clinical study is currently underway at our institution to address the optimal parotid dose-volume needs to be spared to prevent xerostomia and to improve the quality of life in patients with NPC.
我们研究了鼻咽癌(NPC)的断层放疗调强放射治疗(IMRT)和固定野IMRT的靶区覆盖和正常组织保护情况,并与传统射野布置进行比较。在马林克罗特放射研究所,12例NPC患者(T2 - 4N1 - 3M0)接受了计算机断层扫描模拟。然后将图像传输到虚拟模拟工作站计算机进行靶区勾画。靶区大体肿瘤体积(GTV)包括处方剂量为70 Gy的鼻咽原发肿瘤(GTV(NP))、处方剂量为70 Gy的颈部肿大淋巴结(GTV(LN))以及处方剂量为60 Gy的未受累颈部淋巴组织[指定为临床靶体积(CTV)]。还勾画了包括腮腺、脊髓、脑干、下颌骨和垂体在内的关键器官。传统射野布置按照肿瘤协作组(SWOG、RTOG、ECOG)NPC研究0099的指南设计,其中剂量规定在中心轴,靶区体积旨在接受规定剂量±10%。采用类似的剂量学标准评估IMRT的靶区覆盖能力。断层放疗IMRT使用0.86 cm宽的多叶准直器进行计划,而固定野IMRT则使用具有五个等间隔固定机架角度的动态多叶准直器系统。从三维或IMRT治疗计划计算机系统中各器官的剂量体积直方图获取接受特定预定义阈值剂量的每个关键器官的部分体积。采用统计分析(配对t检验)检验统计学意义。我们发现,断层放疗与传统技术实现了相似的靶区覆盖(97.8±2.3%对98.9±1.3%)。静态野IMRT技术(五个等间隔野)较差,92.1±8.6%的GTV(NP)部分接受70 Gy±10%剂量(P<0.05)。然而,两种IMRT技术对70 Gy的GTV(LN)覆盖均显著更好(断层放疗、固定野IMRT和传统治疗分别为96.1±3.2%、87.7±10.6%和42.2±21%)。IMRT技术对60 Gy的CTV覆盖也显著更好。通过评估接受超过30 Gy的腮腺部分体积来量化腮腺保护情况;断层放疗、固定野IMRT和传统治疗分别有66.6±15%、48.3±4%和93±10%的腮腺体积接受超过30 Gy(P<0.05)。尽管靶区覆盖不太理想,但固定野IMRT技术具有最佳的腮腺保护效果。垂体、下颌骨、脊髓和脑干在两种IMRT技术下也得到了更好的保护。这些令人鼓舞的剂量学结果证实了逆向计划IMRT在NPC治疗中的理论优势。我们表明,与传统射野布置相比,原发肿瘤的靶区覆盖得以维持,淋巴结覆盖得到改善。IMRT保护腮腺的能力令人兴奋,我们机构目前正在进行一项前瞻性临床研究,以确定为预防口干和改善NPC患者生活质量需要保护的最佳腮腺剂量体积需求。